Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients - Schiesser, D; Binet, I; Tsinalis, D; Dickenmann, M; Keusch, G; Schmidli, M (Neprol Dial Transplant., 2006)
et al